The CEOs of both Wheeler Bio and Charles River express optim...

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

5797 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

3181Followers

0Following

7947Visitors